TNFSF10 and neoplasm: Moreover, the endogenous TRAIL signaling pathway can recruit immunosuppressive TAMs by inducing tumor cells to secrete the cytokine CCL2, promoting an immunosuppressive microenvironment and inhibiting cytotoxic T lymphocyte (CTL) activation [19].